Cadrenal Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Cadrenal Therapeutics, Inc. (CVKD) had Lessee, Operating Lease, Liability, to be Paid, Year One of $9.38 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-13
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $9.38K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $16.41K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $23.44K.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $22.74K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $9.38K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $16.41K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $23.44K 10-K · filed 2026-03-31 |
| 2024-12-31 | $22.74K 10-K · filed 2025-03-13 |
| 2023-12-31 | $22.32K 10-K · filed 2024-03-11 |
| 2023-09-30 | $6.57K 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B |